By Harnessing the Power of Human Derived Antibodies,

We’re Innovating Cancer Treatment.

About US

Grid Therapeutics is an emerging clinical stage biotechnology company located in Durham, North Carolina. We have made a commitment to our patients and families to develop better and safer therapeutic antibodies for cancer.

Learn more

R&D

Based on fundamental principles of anti-tumor immunity, Grid Therapeutics has a unique strategy to rapidly and efficiently develop novel tumor-specific therapeutic antibodies for the treatment of multiple cancer types directly from single human B cells.

Learn more

LATEST NEWS

Keep yourself updated with the latest news from Grid. Check back regularly for new content posted weekly about cancer treatment and the search for a cure!

Learn more